Storia in 2 fonti

FDA Classifies Insulet Omnipod Recall as Serious After Injury Reports - Insulet (NASDAQ:PODD)

FDA classified Insulet's Omnipod pod recall as Class I after reports of insulin under-delivery linked to 24 serious injuries.

Raccontata da

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

benzinga.comStai leggendo2 mesi fa

FDA classified Insulet's Omnipod pod recall as Class I after reports of insulin under-delivery linked to 24 serious injuries.

PODD Fraud Alert: Insulet Corporation Sued for Securities Fraud after Safety Issues Lead to a 6% Stock Drop – Investors Notified to Contact BFA Law